Interní Med. 2012; 14(6-7): 257-260

Aging men and steroid hormones. 2. Adrenopause

prof.MUDr.RNDr.Luboslav Stárka, DrSc.
Endokrinologický ústav, Praha

In the course of aging the hormonal regulation originating in the axis hypothalamus-pituitary-adrenals is changed. The levels of dehydroepiandrosterone

(DHEA) decrease markedly, whereas cortisol secretion has tendency to increase. In such way the ratio cortisol/DHEA

increases followed by a shift from anabolism to catabolism, from support of immunity processes to their partial inhibition and to the

change of neurosteroid activity in the brain. Damped secretion activity is recorded also in adrenal z. glomerulosa and in the course of

aging the sensitivity of aldosterone secretion to various challenges is changed. Deficit of DHEA in some limited cases can be ameliorated

by supplementation with DHEA; the consequences of higher aldosterone secretion can be corrected by antimineralo-corticoid drugs as

spirolactone, ACE-inhibitors or sartanes. Selectively acting anti-mineralocorticoid is not for disposition until now.

Keywords: aging, cortisol, aldosterone, dehydroepiandrosterone, civilisation diseases

Published: July 31, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stárka L. Aging men and steroid hormones. 2. Adrenopause. Interní Med. 2012;14(6-7):257-260.
Download citation

References

  1. Stárka L. Endokrinologie stárnutí. Interna pro praxi. 2002; 4: 280-289.
  2. Giordano R, Bo M, Pellegrino M, Vezzari M, et al. Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade. J Clin Endocrinol Metab. 2005; 90(10): 5656-5662. Go to original source... Go to PubMed...
  3. Giordano R, Di Vito L, Lanfranco F, et al. Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH (1-24). Clin Endocrinol (Oxf). 2001; 55(2): 259-265. Go to original source... Go to PubMed...
  4. Ferrari M, Mantero F. Male aging and hormones: the adrenal cortex. J Endocrinol Invest. 2005; 28(11 Suppl Proceedings): 92-95.
  5. Šulcová J, Hampl R, Hill M, Stárka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J. Endocr. 1997; 154: 57-62. Go to original source... Go to PubMed...
  6. Baulieu EE. Dehydroepiandrosterone (DHEA): a fountain of youth. J Clin Endocrinol Metab 1996; 81: 3147-3151. Go to original source... Go to PubMed...
  7. Chehab O, Ouertani M, Chaieb K, et al. Hormonal status of cortisol and dehydroepiandrosterone sulfate in an elderly Tunisian population. C R Biol. 2007; 330(10): 755-763. Go to original source... Go to PubMed...
  8. Arlt W. Dehydroepiandrosterone and ageing. Best Pract Res Clin Endocrinol Metab. 2004; 18(3): 363-380. Go to original source... Go to PubMed...
  9. Elmlinger MW, Dengler T, Weinstock C, Kuehnel W. Endocrine alterations in the aging male. Clin Chem Lab Med. 2003; 41(7): 934-941. Go to original source... Go to PubMed...
  10. Agbedia OO, Varma VR, Seplaki CL, et al. Blunted diurnal decline of cortisol among older adults with low socioeconomic status. Ann N Y Acad Sci. 2011; 1231: 56-64. Go to original source... Go to PubMed...
  11. Valenti G. Neuroendocrine hypothesis of aging: the role of corticoadrenal steroids. J Endocrinol Invest. 2004; 27(Suppl 6): 62-63. Go to PubMed...
  12. Holmes MC, Seckl JR. Mol Cell Endocrinol. The role of 11beta-hydroxysteroid dehydrogenases in the brain. 2006; 248(1-2): 9-14. Go to original source... Go to PubMed...
  13. Lupien SJ, Schwartz G, Ng YK, Fiocco A, et al. The Douglas Hospital longitudinal study of normal and pathological aging: summary of findings. J Psychiatry Neurosci. 2005; 30(5): 328-334.
  14. Hartaigh BO, Loerbroks A, Thomas GN, et al. Age-dependent and -independent associations between depression, anxiety, DHEAS, and cortisol: From the MIPH Industrial Cohort Studies (MICS). Psychoneuroendocrinology. 2011; 30. Go to original source... Go to PubMed...
  15. de Bruin VM, Vieira MC, Rocha MN, Viana GS. Cortisol and dehydroepiandosterone sulfate plasma levels and their relationship to aging, cognitive function, and dementiaBrain Cogn. 2002; 50(2): 316-323. Go to original source... Go to PubMed...
  16. McAuley MT, Kenny RA, Kirkwood TB, et al. A mathematical model of aging-related and cortisol induced hippocampal dysfunction. BMC Neurosci. 2009; 25(10): 26. Go to original source... Go to PubMed...
  17. Li G, Cherrier MM, Tsuang DW, Petrie EC, et al. Salivary cortisol and memory function in human aging. Neurobiol Aging. 2006; 27(11): 1705-1714. Go to original source... Go to PubMed...
  18. Buoso E, Lanni C, Molteni E, et al. Opposing effects of cortisol and dehydroepiandrosterone on the expression of the receptor for Activated C Kinase 1: implications in immunosenescence. Exp Gerontol. 2011; 46(11): 877-883. Go to original source... Go to PubMed...
  19. Khanfer R, Lord JM, Phillips AC. Neutrophil function and cortisol: DHEAS ratio in bereaved older adults. Brain Behav Immun. 2011; 25(6): 1182-1186. Go to original source... Go to PubMed...
  20. Bičíková M, Stárka L. Inhibice 11?-hydroxysteroidní dehydrogenázy typu 1 jako možná cesta léčby diabetu, obezity a metabolického syndromu. DMEV 2011; 14(2): 61-66.
  21. Martins LC, Figueiredo VN, Quinaglia T, et al. Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness. J Hum Hypertens. 2011; 25(9): 532-538. Go to original source... Go to PubMed...
  22. Safar ME. Arterial aging-hemodynamic changes and therapeutic options. Nat Rev Cardiol. 2010; 7(8): 442-449. Go to original source... Go to PubMed...
  23. McCurley A, Jaffe IZ. Mineralocorticoid receptors in vascular function and disease. Mol Cell Endocrinol. 2012; 350(2): 256-265. Go to original source... Go to PubMed...
  24. Burton LA, McMurdo ME, Struthers AD. Mineralocorticoid antagonism: a novel way to treat sarcopenia and physical impairment in older people? Clin Endocrinol (Oxf). 2011; 75(6): 725-729. Go to original source... Go to PubMed...
  25. Yau JL, Noble J, Seckl JR. 11beta-hydroxysteroid dehydrogenase type 1 deficiency prevents memory deficits with aging by switching from glucocorticoid receptor to mineralocorticoid receptor-mediated cognitive control. J Neurosci. 2011; 31(11): 4188-4193. Go to original source... Go to PubMed...
  26. Benetos A, Gardner JP, Kimura M, et al. Aldosterone and telomere length in white blood cells. J Gerontol A Biol Sci Med Sci. 2005; 60(12): 1593-1596. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.